(19)
(11) EP 3 941 531 A1

(12)

(43) Date of publication:
26.01.2022 Bulletin 2022/04

(21) Application number: 20777784.8

(22) Date of filing: 23.03.2020
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/5154; C12N 15/88; A61K 2039/5152; A61K 2039/55555; A61K 39/39
(86) International application number:
PCT/US2020/024220
(87) International publication number:
WO 2020/198145 (01.10.2020 Gazette 2020/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 22.03.2019 US 201962822385 P

(71) Applicant: The Johns Hopkins University
Baltimore, Maryland 21218 (US)

(72) Inventors:
  • GREEN, Jordan J.
    Baltimore, Maryland 21218 (US)
  • TZENG, Stephany Yi
    Baltimore, Maryland 21218 (US)
  • WILSON, David
    Baltimore, Maryland 21218 (US)
  • MEYER, Randall A.
    Baltimore, Maryland 21218 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS